Institution profile

医療法人社団 盛心会 タカラクリニック

Explore the institution's name, address and registered technologies as published, along with plan classifications, score components and sources.

The ranking reflects only the registration data published by Japan's Ministry of Health, Labour and Welfare; it does not represent treatment outcomes or quality of care. Scoring method →

Source: Ministry of Health, Labour and Welfare public directory of regenerative medicine providers MHLW e-Regenerative Medicine public register · Directory archive date I: 2026-07-19 / II: 2026-09-26 / III: 2026-05-18 · Internet Archive

MHLW e-Regenerative Medicine public registerPublic document number 02C1905014 +5

Location

Prefecture
Tokyo
Address
品川区東五反田2-3-2 タイセイビル9F

Plan classification

  • Class INot registered
  • Class IIThe medium-risk category under the law.
  • Class IIIThe low-risk category under the law.

Certified committee for regenerative medicine

  • 安全未来特定認定再生医療等委員会
  • 令和再生医療委員会
  • 医療法人清悠会認定再生医療等委員会
  • +1

Public score

63.9/ 100

A · Review level
25.0 / 30
B · Technologies
22.4 / 35
C · Coverage
10.7 / 25
D · Class I / II technologies
5.8 / 10

The public score is calculated from public registration information and does not reflect quality of care. Scoring method →

Position in the overall score distribution

0–100 · Public score
000–9.9 · 0 institutions
01010–19.9 · 0 institutions
2172020–29.9 · 217 institutions
3163030–39.9 · 316 institutions
7564040–49.9 · 756 institutions
2465050–59.9 · 246 institutions
1326060–69.9 · 132 institutions
417070–79.9 · 41 institutions
248080–89.9 · 24 institutions
49090–100 · 4 institutions
This institution 63.9
Public score →100

Registered technologies (6)

Stem cells (all sources) 3
Registered technologies · Japanese originalTechnology areasPlan classification
自己脂肪由来間葉系幹細胞を用いた変形性関節症治療Stem cells (all sources)Adipose-derived stem cellsJoints and musculoskeletalClass II
脂肪由来間葉系幹細胞を用いた慢性疼痛の治療Stem cells (all sources)Adipose-derived stem cellsClass II
フレイル進行抑制及びフレイル進行予防のための自己脂肪由来間葉系幹細胞による治療Stem cells (all sources)Adipose-derived stem cellsClass II
Adipose-derived stem cells 3
Registered technologies · Japanese originalTechnology areasPlan classification
自己脂肪由来間葉系幹細胞を用いた変形性関節症治療Stem cells (all sources)Adipose-derived stem cellsJoints and musculoskeletalClass II
脂肪由来間葉系幹細胞を用いた慢性疼痛の治療Stem cells (all sources)Adipose-derived stem cellsClass II
フレイル進行抑制及びフレイル進行予防のための自己脂肪由来間葉系幹細胞による治療Stem cells (all sources)Adipose-derived stem cellsClass II
NK and immune cells 3
Registered technologies · Japanese originalTechnology areasPlan classification
自家NK細胞療法NK and immune cellsClass III
TCTP療法 (自家樹状細胞(DC)および自家マクロファージ(Mφ)の局所投与、 自家活性化Tリンパ球(AT)を血管投与する細胞療法)NK and immune cellsClass III
自家CAT細胞療法NK and immune cellsClass III
Joints and musculoskeletal 1
Registered technologies · Japanese originalTechnology areasPlan classification
自己脂肪由来間葉系幹細胞を用いた変形性関節症治療Stem cells (all sources)Adipose-derived stem cellsJoints and musculoskeletalClass II

Certified committee for regenerative medicine

  • 安全未来特定認定再生医療等委員会
  • 令和再生医療委員会
  • 医療法人清悠会認定再生医療等委員会
  • 医療法人清悠会 認定再生医療等委員会

Public document number

  • 02C1905014
  • 01C2502069
  • 02C2305058
  • 02C2601063
  • 02C1902047
  • 02C1902048
Plan classification · Certified committee for regenerative medicine · Public document number
Registered technologiesPlan classificationCertified committee for regenerative medicinePublic document number
自己脂肪由来間葉系幹細胞を用いた変形性関節症治療Class II安全未来特定認定再生医療等委員会02C1905014
フレイル進行抑制及びフレイル進行予防のための自己脂肪由来間葉系幹細胞による治療Class II令和再生医療委員会01C2502069
脂肪由来間葉系幹細胞を用いた慢性疼痛の治療Class II安全未来特定認定再生医療等委員会02C2305058
TCTP療法 (自家樹状細胞(DC)および自家マクロファージ(Mφ)の局所投与、 自家活性化Tリンパ球(AT)を血管投与する細胞療法)Class III医療法人清悠会認定再生医療等委員会02C2601063
自家CAT細胞療法Class III医療法人清悠会 認定再生医療等委員会02C1902047
自家NK細胞療法Class III医療法人清悠会 認定再生医療等委員会02C1902048

Other institutions in the same prefecture

← Institution directory
One-to-one advice

Still unsure? Ask an advisor

Use the “Chat with an advisor” button on this page (at the bottom of the screen on mobile, bottom right on desktop) to open a chat with the Stem Cell Japan advice desk. Consultation and coordination are free, and an advisor replies within one working day.

Chat with an advisor